PrEP

;
Biomedical HIV Prevention Summit: Scaling Up PrEP Now by Leveraging Existing Programs

Biomedical HIV Prevention Summit: Scaling Up PrEP Now by Leveraging Existing Programs

Apr 9, 2024

HIV+Hepatitis Policy Institute will convene a panel on Friday, April 19, 2024, at the Biomedical HIV Prevention Summit to examine how PrEP is provided today by entities including community health centers, CBOs, pharmacies, telemedicine platforms, and state health departments. We will examine how this work is financed by leveraging existing programs and systems, as well as current barriers and what can be done to close PrEP access gaps in underserved populations.

read more

North Carolina Blue Cross Blue Shield HIV Drug Tiers

Sep 12, 2023

Carl Schmid discusses NC Blue Cross Blue Shield’s decision to remove HIV drugs from the highest and costliest drug tiers following a discrimination complaint filed by the HIV+Hepatitis Policy Institute and NC AIDS Action Network.

read more
Improving access to preventive services consumer protections

Improving access to preventive services consumer protections

Aug 11, 2023

At the NAIC meeting, Carl Schmid and colleagues present consumer representatives’ report on investigation of how insurers are implementing ACA preventive service requirements, including PrEP, and urge state regulators to take action to ensure insurers are compliant with the law.

read more

Search

Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing Drug Pricing healthcare Hepatitis Hepatitis B Hepatitis C HIV HIV Prevention Insurers Medicaid NAIC PBMs PrEP Prescription Drugs Private Insurance Ryan White Program state Testing transparency Treatment Trump administration

Recent Presentations

Pin It on Pinterest